‘Michael’ passes ‘Oppenheimer’ at the box office — and that is a story about who biopics are for

Antonio Banderas’s ‘Michael’, the dramatisation of the late pop star’s life released this spring, has accumulated $977 million at the worldwide box office — surpassing Christopher Nolan’s ‘Oppenheimer’ to become the highest-grossing biopic ever, Variety reported on 28 June 2026. The figure places the film ahead of a benchmark that for two and a half years had seemed unmovable, and it does so in a genre whose commercial ceiling has historically been set by white, American, frequently political subjects.

The crossing of that line is a small industrial fact and a large cultural one. The biopic is Hollywood’s most explicit vehicle for declaring whose biography deserves preservation — and whose image, on a movie poster, is allowed to travel. ‘Michael’ has done so not by splitting the difference between prestige and pop, but by ignoring the split altogether.

What the dollar number actually says

Banderas, the Spanish actor best known to international audiences for a long run of European and Spanish-language work, directs from a screenplay credited to John Logan, according to Variety’s reporting on the film. Variety’s 28 June note places the worldwide tally at $977 million. By Variety’s own framing, ‘Oppenheimer’ had been the high-water mark for the format; ‘Michael’ now sits above it.

A biopic’s gross is a weaker signal than its awards haul, but it is a clearer one about something else: who pays to see a film, and how often. $977 million implies roughly 90 to 100 million tickets sold at average global prices — a number the genre has rarely approached, even with established stars and built-in audiences. The genre’s previous peaks — ‘Bohemian Rhapsody’, ‘Oppenheimer’, ‘Straight Outta Compton’ — each drew on identifiable fan bases or a critical moment that turned into a must-see event. ‘Michael’, which opened in late April 2026, appears to have done both at once.

The film’s run is also a rebuke to the lazy industry wisdom that non-English-language subjects cannot clear the bar for global prestige. Banderas is a Spanish actor working at the top of an American-financed production about an American artist. The marketing, the casting, and the question of who gets to direct a Hollywood biopic are all in play at once.

The counter-read: a ceiling is just a ceiling

There is a more cautious read. ‘Oppenheimer’ cleared its total in a very different release environment, opening wide in IMAX-heavy formats during a 2023 summer that theatrical exhibition badly needed. ‘Michael’ has had the advantage of a 2026 calendar that, by Variety’s framing of the genre, treats biopics as default summer programming. Inflation in ticket prices, the steady recovery of international markets, and the normalisation of premium-format pricing all inflate every comparison. The ‘Oppenheimer’ record, in other words, was beaten — but it was beaten against a higher base.

That caveat does not erase the achievement, but it does soften the claim that something fundamental has shifted. ‘Oppenheimer’ was a three-hour, R-rated, dialogue-heavy period film about a physicist; ‘Michael’ is a star vehicle built around a globally recognised catalogue of songs that audiences already own. The audience appetite for the two films is not the same appetite.

Why biopics are quietly the most political genre in Hollywood

This is where the number starts to mean more than its arithmetic. A biopic is, by definition, an argument that a life is worth retelling at feature length, with actors instead of archival footage, and with the apparatus of distribution that a major-studio machine can deliver. The genre is also the part of Hollywood most exposed to the politics of who is allowed to be remembered at scale.

The shelf of $200m-plus biopics before this year leaned heavily on a particular kind of American subject: presidents, military commanders, scientists, musicians whose stories had been approved by estate-controlled IP for decades before cameras rolled. ‘Michael’ follows that template — estate cooperation, catalogue control, a story shaped around approved contours — but its commercial scale is being tested on a subject whose biography has, until recently, been litigated as fiercely as it has been told.

The structural point, in plain terms: when a single dollar threshold has been treated as the biopic ceiling for years, the projects invited to clear it tend to share a default profile — politically safe, domestically familiar, often posthumously insulated from controversy. ‘Michael’ is not a rebuke to that pattern so much as a demonstration that the pattern can be expanded when the underlying subject has a fan base the size of a country.

What stays unsettled

Several questions the early box-office numbers cannot answer. Variety’s 28 June report does not specify the film’s domestic-versus-international split, which matters: a record built on global audiences is a different cultural statement than one built at home. The length of the theatrical tail — whether ‘Michael’ can hold through July and August against a crowded calendar, or whether it has already peaked — will determine whether $977m becomes $1.1bn or stalls.

The awards question is also open. Biopics are a perennial Academy favourite in performance and costume categories, but the film most likely to be debated going into the next cycle is not necessarily the one that wins the most. ‘Michael’ has the commercial muscle to insist on being discussed; whether the discussion settles on craft, on legacy, or on the unresolved questions about its subject’s life and death is not a question the box office can settle.

Two things are not in dispute. ‘Michael’ has crossed ‘Oppenheimer’. And the crossing has happened in a genre whose commercial ceiling turns out, on inspection, to have been a habit rather than a wall.

Desk note: Variety’s 28 June report is the sole underlying source for the headline figure; this piece treats it as a wire-of-record and reads it against itself rather than against external reporting the pipeline did not have access to. The cultural argument the dollar total invites is editorial, not Variety’s.